NCCN Guidelines® insights breast cancer, version 1.2017

Featured updates to the NCCN Guidelines

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth M. O'Regan, Sameer A. Patel & 13 others Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee Schwartzberg, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.

Original languageEnglish (US)
Pages (from-to)433-451
Number of pages19
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Guidelines
Breast Neoplasms
Drug Approval
Radiotherapy
Hormones
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., ... Kumar, R. (2017). NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 15(4), 433-451. https://doi.org/10.6004/jnccn.2017.0044

NCCN Guidelines® insights breast cancer, version 1.2017 : Featured updates to the NCCN Guidelines. / Gradishar, William J.; Anderson, Benjamin O.; Balassanian, Ron; Blair, Sarah L.; Burstein, Harold J.; Cyr, Amy; Elias, Anthony D.; Farrar, William B.; Forero, Andres; Giordano, Sharon Hermes; Goetz, Matthew P.; Goldstein, Lori J.; Isakoff, Steven J.; Lyons, Janice; Kelly Marcom, P.; Mayer, Ingrid A.; McCormick, Beryl; Moran, Meena S.; O'Regan, Ruth M.; Patel, Sameer A.; Pierce, Lori J.; Reed, Elizabeth C.; Salerno, Kilian E.; Schwartzberg, Lee; Sitapati, Amy; Smith, Karen Lisa; Smith, Mary Lou; Soliman, Hatem; Somlo, George; Telli, Melinda; Ward, John H.; Shead, Dorothy A.; Kumar, Rashmi.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 4, 01.04.2017, p. 433-451.

Research output: Contribution to journalArticle

Gradishar, WJ, Anderson, BO, Balassanian, R, Blair, SL, Burstein, HJ, Cyr, A, Elias, AD, Farrar, WB, Forero, A, Giordano, SH, Goetz, MP, Goldstein, LJ, Isakoff, SJ, Lyons, J, Kelly Marcom, P, Mayer, IA, McCormick, B, Moran, MS, O'Regan, RM, Patel, SA, Pierce, LJ, Reed, EC, Salerno, KE, Schwartzberg, L, Sitapati, A, Smith, KL, Smith, ML, Soliman, H, Somlo, G, Telli, M, Ward, JH, Shead, DA & Kumar, R 2017, 'NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 4, pp. 433-451. https://doi.org/10.6004/jnccn.2017.0044
Gradishar, William J. ; Anderson, Benjamin O. ; Balassanian, Ron ; Blair, Sarah L. ; Burstein, Harold J. ; Cyr, Amy ; Elias, Anthony D. ; Farrar, William B. ; Forero, Andres ; Giordano, Sharon Hermes ; Goetz, Matthew P. ; Goldstein, Lori J. ; Isakoff, Steven J. ; Lyons, Janice ; Kelly Marcom, P. ; Mayer, Ingrid A. ; McCormick, Beryl ; Moran, Meena S. ; O'Regan, Ruth M. ; Patel, Sameer A. ; Pierce, Lori J. ; Reed, Elizabeth C. ; Salerno, Kilian E. ; Schwartzberg, Lee ; Sitapati, Amy ; Smith, Karen Lisa ; Smith, Mary Lou ; Soliman, Hatem ; Somlo, George ; Telli, Melinda ; Ward, John H. ; Shead, Dorothy A. ; Kumar, Rashmi. / NCCN Guidelines® insights breast cancer, version 1.2017 : Featured updates to the NCCN Guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 4. pp. 433-451.
@article{9e1b5bdbf2b84d3da00528ccf468c6a0,
title = "NCCN Guidelines{\circledR} insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines",
abstract = "These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.",
author = "Gradishar, {William J.} and Anderson, {Benjamin O.} and Ron Balassanian and Blair, {Sarah L.} and Burstein, {Harold J.} and Amy Cyr and Elias, {Anthony D.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Goetz, {Matthew P.} and Goldstein, {Lori J.} and Isakoff, {Steven J.} and Janice Lyons and {Kelly Marcom}, P. and Mayer, {Ingrid A.} and Beryl McCormick and Moran, {Meena S.} and O'Regan, {Ruth M.} and Patel, {Sameer A.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Salerno, {Kilian E.} and Lee Schwartzberg and Amy Sitapati and Smith, {Karen Lisa} and Smith, {Mary Lou} and Hatem Soliman and George Somlo and Melinda Telli and Ward, {John H.} and Shead, {Dorothy A.} and Rashmi Kumar",
year = "2017",
month = "4",
day = "1",
doi = "10.6004/jnccn.2017.0044",
language = "English (US)",
volume = "15",
pages = "433--451",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - NCCN Guidelines® insights breast cancer, version 1.2017

T2 - Featured updates to the NCCN Guidelines

AU - Gradishar, William J.

AU - Anderson, Benjamin O.

AU - Balassanian, Ron

AU - Blair, Sarah L.

AU - Burstein, Harold J.

AU - Cyr, Amy

AU - Elias, Anthony D.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goetz, Matthew P.

AU - Goldstein, Lori J.

AU - Isakoff, Steven J.

AU - Lyons, Janice

AU - Kelly Marcom, P.

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Moran, Meena S.

AU - O'Regan, Ruth M.

AU - Patel, Sameer A.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Salerno, Kilian E.

AU - Schwartzberg, Lee

AU - Sitapati, Amy

AU - Smith, Karen Lisa

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Somlo, George

AU - Telli, Melinda

AU - Ward, John H.

AU - Shead, Dorothy A.

AU - Kumar, Rashmi

PY - 2017/4/1

Y1 - 2017/4/1

N2 - These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.

AB - These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.

UR - http://www.scopus.com/inward/record.url?scp=85017528550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017528550&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0044

DO - 10.6004/jnccn.2017.0044

M3 - Article

VL - 15

SP - 433

EP - 451

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -